Daily micro-dose TRT injections: smoother hormones or gym-bro mythology?

What did @shoobie_doubie actually say?

The creator switched from twice-weekly injections using a 22-gauge, 1-inch needle to daily injections with a 27-gauge half-inch needle, using a 1ml syringe. The argument is threefold: smaller, more frequent shots reduce scar tissue, keep hormone levels "a lot more balanced," and eliminate the peaks and troughs visible on blood work. They also note they're actually injecting more total oil now, just spread across seven shots instead of two.

This is a real practice in TRT circles, and the reasoning isn't made up. Daily or every-other-day subcutaneous or intramuscular injections have moved from fringe preference to a legitimate clinical conversation. The creator isn't selling anything here. They're describing a personal protocol and inviting others to share theirs. That context matters when weighing how the advice lands.

Does the science back this up?

Mostly, yes, though the evidence is stronger for some claims than others. The pharmacokinetics argument is the most solid. More frequent injections of testosterone cypionate or enanthate do produce flatter serum testosterone curves. The scar tissue claim is biologically plausible but less rigorously studied in TRT-specific populations.

A 2017 study by Kaminetsky et al. in The Journal of Sexual Medicine compared weekly versus more frequent testosterone cypionate dosing and found that more frequent administration reduced peak-to-trough variability, which tracks with what the creator describes as fewer "peaks and troughs." Subcutaneous testosterone delivery has also been documented in clinical literature, including a 2012 paper by Spratt et al. in The Journal of Clinical Endocrinology and Metabolism, which found subcutaneous injections produced stable levels with less volume per shot. The half-inch needle length is consistent with subcutaneous delivery in most adults, which is a meaningful distinction the creator doesn't explicitly make but implicitly practices.

The scar tissue reduction claim is supported by general injection site trauma literature. Smaller gauge needles cause less mechanical tissue disruption, but the long-term comparative data in TRT patients specifically is limited.

What did they get wrong (or right)?

They got the core pharmacology right. Credit where it's due. The claim about hormone stability with daily dosing is accurate for esterified testosterone formulations. Where things get fuzzy is the blanket recommendation to use a half-inch needle without specifying the injection route. A half-inch needle works for subcutaneous injection in most body compositions, but intramuscular injection in the glute or lateral thigh often requires longer needles to reach the muscle belly, particularly in individuals with higher body fat.

The creator says "I highly recommend" the smaller needle setup without flagging that needle length appropriateness depends on injection site and individual anatomy. That omission isn't dangerous at the level of this video, but it's the kind of shortcut that gets repeated without context. Someone with higher body fat attempting an IM injection with a half-inch needle into the glute may not reach muscle tissue, which affects absorption. The creator also doesn't distinguish between subcutaneous and intramuscular delivery, which have meaningfully different absorption profiles even with the same ester.

• Correct: More frequent dosing reduces serum testosterone variability
• Correct: Smaller gauge needles reduce mechanical tissue trauma
• Incomplete: Needle length recommendations depend on injection site and body composition
• Missing: No distinction between subcutaneous and intramuscular delivery

What should you actually know?

If you're on a physician-supervised TRT protocol, the frequency and injection method in this video reflect practices that legitimate clinicians do use. Daily subcutaneous injections have gained traction in clinical TRT management precisely because of the stability argument the creator makes. But the word "supervised" is doing real work in that sentence.

Changing injection frequency, gauge, needle length, or route without medical guidance isn't a cosmetic tweak. It affects how much testosterone actually reaches circulation, how quickly, and how consistently. A protocol optimized for twice-weekly IM injections needs reassessment if you switch to daily subcutaneous, including follow-up blood work to confirm levels are where they should be. The creator doesn't mention blood work follow-up after changing their protocol, which is a gap worth naming.

Also worth noting: the hashtag mix here includes both "trt" and "gear," which signals this content is reaching both medically supervised patients and people using testosterone outside a clinical setting. The advice isn't identical for those two groups, and the video doesn't draw that line. Anyone considering a protocol change based on social media content should have that conversation with a licensed provider who can order the labs to verify what their hormones are actually doing.